WO2000025743A3 - Compositions ameliorees stimulant la croissance - Google Patents

Compositions ameliorees stimulant la croissance Download PDF

Info

Publication number
WO2000025743A3
WO2000025743A3 PCT/US1999/023993 US9923993W WO0025743A3 WO 2000025743 A3 WO2000025743 A3 WO 2000025743A3 US 9923993 W US9923993 W US 9923993W WO 0025743 A3 WO0025743 A3 WO 0025743A3
Authority
WO
WIPO (PCT)
Prior art keywords
growth stimulant
improved growth
release
stimulant compositions
improved
Prior art date
Application number
PCT/US1999/023993
Other languages
English (en)
Other versions
WO2000025743A2 (fr
Inventor
Chung Shih
Thomas J Kennedy
Peter James Knight
Daniel S Robins
Zezhi Jesse Shao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to AU30967/00A priority Critical patent/AU777393B2/en
Priority to CA002348841A priority patent/CA2348841C/fr
Priority to BRPI9914996 priority patent/BRPI9914996B8/pt
Priority to BR9914996-6A priority patent/BR9914996A/pt
Publication of WO2000025743A2 publication Critical patent/WO2000025743A2/fr
Publication of WO2000025743A3 publication Critical patent/WO2000025743A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Agent amélioré stimulant la croissance et la prise de poids pour des animaux domestiques, tels que les bovins, les porcs et les moutons, constitué d'un anabolisant administré par voie sous-cutanée sous forme d'une composition implantée à double libération. Les gains de croissance et de poids sont particulièrement accrus lorsque du zéranol est administré sous forme de composition à libération immédiate puis à libération prolongée, ce qui permet l'injection de la dose en une seule fois.
PCT/US1999/023993 1998-11-04 1999-11-02 Compositions ameliorees stimulant la croissance WO2000025743A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU30967/00A AU777393B2 (en) 1998-11-04 1999-11-02 Improved growth stimulant compositions
CA002348841A CA2348841C (fr) 1998-11-04 1999-11-02 Compositions ameliorees stimulant la croissance
BRPI9914996 BRPI9914996B8 (pt) 1998-11-04 1999-11-02 composição de implante anabólico e processo para estimular a taxa aumentada de crescimento, maior quantidade de crescimento e maior eficiência de ração em um animal.
BR9914996-6A BR9914996A (pt) 1998-11-04 1999-11-02 Composições estimulantes de crescimento melhorado

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04
US09/185,944 1998-11-04

Publications (2)

Publication Number Publication Date
WO2000025743A2 WO2000025743A2 (fr) 2000-05-11
WO2000025743A3 true WO2000025743A3 (fr) 2000-08-24

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/023993 WO2000025743A2 (fr) 1998-11-04 1999-11-02 Compositions ameliorees stimulant la croissance

Country Status (11)

Country Link
AR (1) AR025133A1 (fr)
AU (1) AU777393B2 (fr)
BR (2) BR9914996A (fr)
CA (1) CA2348841C (fr)
CO (1) CO5140100A1 (fr)
CR (1) CR6351A (fr)
MY (1) MY134868A (fr)
PE (1) PE20001092A1 (fr)
TW (1) TWI250027B (fr)
WO (1) WO2000025743A2 (fr)
ZA (1) ZA200103494B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4001289B1 (fr) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé amélioré de préparation de trenbolone et/ou d'acétate de trenbolone
EP4001288A1 (fr) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé de préparation d'acétate de trenbolone présentant une distribution granulométrique définie et un habitus cristallin à plaques irrégulières hexagonales
EP4000688A1 (fr) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé pour la préparation d'acétate trenbolone ayant une distribution granulométrique définie

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167662A (en) * 1984-11-22 1986-06-04 Crb Virbac Sarl Sustained release devices
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167662A (en) * 1984-11-22 1986-06-04 Crb Virbac Sarl Sustained release devices
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
O'CALLAGHAN, D. ET AL: "Effects of long acting and short acting estradiol implants on growth rate and carcass weight of steers", VET. REC. (1986), 119(17), 427-9, XP000907270 *

Also Published As

Publication number Publication date
WO2000025743A2 (fr) 2000-05-11
MY134868A (en) 2007-12-31
ZA200103494B (en) 2002-07-30
AR025133A1 (es) 2002-11-13
BRPI9914996B1 (pt) 2011-11-01
BRPI9914996B8 (pt) 2021-07-06
AU777393B2 (en) 2004-10-14
BRPI9914996A (pt) 2001-07-10
CA2348841C (fr) 2007-04-17
CO5140100A1 (es) 2002-03-22
TWI250027B (en) 2006-03-01
CR6351A (es) 2003-11-20
AU3096700A (en) 2000-05-22
CA2348841A1 (fr) 2000-05-11
PE20001092A1 (es) 2000-10-31
BR9914996A (pt) 2001-07-10

Similar Documents

Publication Publication Date Title
BR0013116B1 (pt) formulaÇÕes orais de dose énica para controlar infestaÇço por ectoparasita em animais de estimaÇço, e seu uso.
CA2046445A1 (fr) Systeme d'amenee a manchon de protection
TR28853A (tr) Terapötik olarak ya da gevis getiren hayvanlarda gelismeyi islah etmek ve yemin degerlendirilmesi icin elverisli olan aktif maddelerin kontrollu olarak koyverilmelerine mahsus bir preparat.
CA2568641A1 (fr) Composition a liberation prolongee
EP0990450A3 (fr) Implant pharmaceutique
WO2000025743A3 (fr) Compositions ameliorees stimulant la croissance
US20010041697A1 (en) Implant composition containing melengestrol acetate and trenbolone acetate
BR0014610B1 (pt) composiÇÕes compreendendo uma mistura sinÉrgica de compostos ativos tendo propriedades inseticidas e acaricidas, uso da referida mistura, e processos para controle de pragas animais e de preparo de pesticidas.
WO1999012552A8 (fr) 9a-AZALIDES UTILISES COMME AGENTS ANTIMICROBIENS VETERINAIRES
EP1510214A3 (fr) 8a-azalides comme agents antimicrobiques vétérinaires
AU4519189A (en) Medicaments for the treatment of toxoplasmosis
TH48412A3 (th) องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง
WO2001045727A3 (fr) Compositions veterinaires
HU9201295D0 (en) Medical preparations for treating cryptosporidiosys
EP1177785A3 (fr) Implant pharmaceutique promoteur de croissance
ECSP993205A (es) Composiciones estimulantes del crecimiento mejoradas (caso aho948)
WO2002038103A3 (fr) Compositions probiotiques et methodes pour lutter contre la bacteriose du betail
MXPA99005235A (es) Composicion antibacteriana oral veterinaria de fluoroquinolona para duracion extendida de terapia ymetodo de tratamiento.
IT1209426B (it) Formulazione a cessione controllata a base di un agente microbico disperso in un copolimero ottenuta da acido latticoe glicolico.
EP1779853A3 (fr) 9a-azalides en tant qu'agents anti-microbiens à usage vétérinaire
UA37266C2 (uk) Спосіб комплектування стада великої рогатої худоби бажаного типу
BR9612813A (pt) Composição antibacteriana de fluoroquinolona veterinária oral para duração prolongada de terapia e método de tratamento

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 30967/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2348841

Country of ref document: CA

Ref country code: CA

Ref document number: 2348841

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 200103494

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/004483

Country of ref document: MX

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
WWG Wipo information: grant in national office

Ref document number: 30967/00

Country of ref document: AU